ArticleVaccine2022

Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study.

Norazida Ab Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.